2 Followers on Owler
OverviewCompetitorsNews & Insights

Lexent Bio Competitors or Alternatives

Lexent Bio's top competitors include Lyell, Pyxis Oncology and Circulogene.

Unlock 19 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Lexent Bio's company profile

Ken Nesmith

Co-Founder & CEO

90/100
1 - 25
$0
$100K - 5M
  • $0
    $100K - 5M
  • 1 - 25
    $0
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $0
  • $100K - 5M
View ProfileView
1
Lexent Bio's Competitor - Lyell logo

Lynn Seely

President & CEO

82/100
270
$1.1B
$ < 1M
  • $1.1B
    $ < 1M
  • 270
    $1.1B
  • $ < 1M
  • 82/100
  • 270
  • $1.1B
  • $ < 1M
View ProfileView
2
Lexent Bio's Competitor - Pyxis Oncology logo

Thomas Civik

Chairman & CEO

- -
60
$452M
$11.5M
  • $452M
    $11.5M
  • 60
    $452M
  • $11.5M
  • - -
  • 60
  • $452M
  • $11.5M
View ProfileView
3
Lexent Bio's Competitor - Circulogene logo

Michael V Mullen

Chairman & CEO

87/100
25 - 100
$8M
$5M - 25M
  • $8M
    $5M - 25M
  • 25 - 100
    $8M
  • $5M - 25M
  • 87/100
  • 25 - 100
  • $8M
  • $5M - 25M
View ProfileView
4
Lexent Bio's Competitor - Arcellx logo

Rami Elghandour

Chairman & CEO

88/100
80
$767.6M
$22.3M
  • $767.6M
    $22.3M
  • 80
    $767.6M
  • $22.3M
  • 88/100
  • 80
  • $767.6M
  • $22.3M
View ProfileView
5
Lexent Bio's Competitor - Guardant Health logo

Helmy Eltoukhy

Co-CEO

41/100
1,790
$3.2B
$1.2B
  • $3.2B
    $1.2B
  • 1,790
    $3.2B
  • $1.2B
  • 41/100
  • 1,790
  • $3.2B
  • $1.2B
View ProfileView
Lexent Bio's top 22 competitors are Lyell, Pyxis Oncology, Circulogene, AstraZeneca, Arcellx, Guardant Health, Genentech, Biocept, Bristol-Myers Squibb, ADC Therapeutics, Astellas, Gilead Sciences, Autolus, Exosome Diagnostics, NextCure, Abcuro, Lunaphore, Immunocore, Agomab, GRAIL, Iovance and Codiak. Together they have raised over 48.0B between their estimated 179.5K employees. Lexent Bio's revenue is the ranked 20th among it's top 10 competitors. The top 10 competitors average 8B. Lexent Bio has 18 employees and is ranked 22th among it's top 10 competitors. The top 10 competitors average 8,160.

Lexent Bio VS Lyell

Lyell is Lexent Bio's #1 rival. Lyell was founded in 2018 in South San Francisco, California. Like Lexent Bio, Lyell also operates in the Biotechnology space. Lyell generates $4.8M less revenue than Lexent Bio.

Lexent Bio VS Pyxis Oncology

Pyxis Oncology is one of Lexent Bio's top competitors. Pyxis Oncology is headquartered in Boston, Massachusetts, and was founded in 2019. Like Lexent Bio, Pyxis Oncology also works within the Biotechnology sector. Pyxis Oncology generates 240% the revenue of Lexent Bio.

Lexent Bio VS Circulogene

Circulogene is seen as one of Lexent Bio's top competitors. Circulogene was founded in 2015, and its headquarters is in Birmingham, Alabama. Like Lexent Bio, Circulogene also works within the Biotechnology sector. Circulogene has 18 more employees than Lexent Bio.

Looking for similar companies to Lexent Bio?

Similar Companies

Biotechnology companies in San Francisco

See 329 companies 
Biotechnology companies in San Francisco Bay Area

See 1,325 companies 
Pharmaceuticals & Biotechnology companies in San Francisco

See 393 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,680 companies 
Biotechnology companies in California

See 3,106 companies 
Biotechnology companies with employees in 1-25 range

See 3,320 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,200 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,522 companies 
Companies in San Francisco with employees in 1-25 range

See 4,683 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Lexent Bio and Lexent Bio's Competitors

October 15, 2026Quartz
Insitro is eligible for up to about $1.46 billion in milestone payments, plus single-digit royalties on global sales...
October 15, 2026Business Wire
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its resea...
October 15, 2026Quartz
Vir Biotechnology will receive $90 million upfront and could earn up to $1.74 billion in later milestone payments...
October 15, 2026GlobalNewswire
Immunocore announces first patient dosed in the Phase 1 trial of...
October 14, 2026Nasdaq
(RTTNews) - AgomAb Therapeutics NV (AGMB) announced that the first patient has been dosed in NOV-ERA, a global Phase 2b trial evaluating Ontunisertib i...
October 14, 2026The Economic Times
Biocon has finalized a global settlement and license agreement with Genentech for its drug Pebrilzo. This agreement addresses all ongoing legal dispute...
Today 12:03 PMPharmabiz
AstraZeneca announced that it has entered into a new strategic drug discovery collaboration and licensing agreement with insitro, a leading artificial ...
October 15, 2026Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #Earnings--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2026 financial results an...
Today 2:51 PMContract Pharma
Collaboration targets MASH and cardiomyopathies in a deal worth up to $1.5 billion....
October 15, 2026Benzinga
AstraZeneca pairs with Insitro on a $1.5B AI collaboration to advance drug targets for MASH and heart conditions.read more...

Frequently Asked Questions about Lexent Bio

  1. Who are Lexent Bio's top competitors?

    Lexent Bio's top 3 competitors are Lyell, Pyxis Oncology, Circulogene.

  2. Who is similar to Lexent Bio?

    Lyell is the most similar to Lexent Bio. Pyxis Oncology and Circulogene are also similar to Lexent Bio.

  1. Are Lexent Bio and Lyell competitors?

    Yes, Lyell is one of Lexent Bio’s top competitors.